ANVISA registration

SS-A/SS-B-HEMAGLUTINACAO

Registration 10280220160. ANTICORPO ANTI-ANTÍGENOS NUCLEARES EXTRAÍVEIS (ENA)

Registration details

Registration number10280220160
Application number253510081650115
Technical nameANTICORPO ANTI-ANTÍGENOS NUCLEARES EXTRAÍVEIS (ENA)
Risk classII
Published on09/08/2001
ValidityIndefinite validity

Registration holder

Legal nameHEMAGEN DIAGNOSTICOS COMERCIO IMP E EXPORTACAO LTDA
CNPJ64.002.686/0001-32

Manufacturer

  • HEMAGEN DIAGNOSTICS INC. ESTADOS UNIDOS DA AMÉRICA

Other registrations held by HEMAGEN DIAGNOSTICOS COMERCIO IMP E EXPORTACAO LTDAview all

ANTICORPO ENDOMISIAL IgA (EmA ) IMUNOFLUORESCENCIA VIRGO

10280220138

JO-1 HEMAGLUTINACAO

10280220152

DNA HEMAGLUTINACAO

10280220153

RF (FATOR REUMATOIDE) HEMAGLUTINACAO

10280220156

RNP/Sm HEMAGLUTINACAO

10280220158

ScI/70 HEMAGLUTINACAO

10280220161

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist